The EPS projection of Marathon Patent Group, Inc. (NASDAQ:MARA) for quarter ended 2016-09-30 is $-0.21. Last week, the EPS forecast was $-0.21 against target of $-0.21, a month earlier. Two months ago, this estimate was $-0.21 versus forecast of $-0.21 three months earlier, implying a deviation of 0%.
Marathon Patent Group, Inc. (NASDAQ:MARA) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 0, and 0, correspondingly.
EPS estimate downgrade for Marathon Patent Group, Inc. (NASDAQ:MARA) in the preceding 30, 120, 60 and 90 days were 0, 1, 2, and 2, correspondingly.
Marathon Patent Group, Inc. (NASDAQ:MARA) EPS target for the quarter closed 1 was $-0.21, based on 2 recommendations. As reported on 2016-05-12 the EPS was $-0.18. The change was $0.06, implying a percentage deviation of 25%. The projections showed a standard deviation of 0.16.
Quarterly Sales Estimates
Marathon Patent Group, Inc. (NASDAQ:MARA) yearly sales prediction for the fiscal 2016 stands at $2.92 and the median estimate is at $2.92. Almost 2 analysts issued sales target.
Highest sales target is $3 while the lowest target is $2.84 showing standard deviation of 0.113%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Marathon Patent Group, Inc. (NASDAQ:MARA) announced that the deviation in forecast was -81.588%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...